A group of Chinese scientists injected a human being with cells genetically edited using CRISPR-Cas9 technology. This is the first time CRISPR has been used on a fully formed adult human and it’s encouraged a biomedical battle between China and the United States.
However, another group of scientists in the U.S. proposed a similar study in June of this year. The $250 million study funded by Sean Parker’s new cancer institute is slated to take place at the University of Pennsylvania. The National Institutes of Health (NIH) has already given the research a thumbs up, but it’s still awaiting approval from the Food and Drug Administration (FDA).
📰Click👆 to read more🔗: https://goo.gl/SR7bM7